Trade Summary

4 days ago, Hussain Abbas, serving as Dir at Moderna, Inc. (MRNA), sold 5,682 shares at $46.63 per share, for a total transaction value of $264,952.00. Following this transaction, Hussain Abbas now holds 12,066 shares of MRNA.

This sale represents a 32.00% decrease in Hussain Abbas's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 4, 2026, 3 days after the trade was made.

Moderna, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.